Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Liquid diet could help malnourished kids with liver problems grow better

NCT ID NCT07569003

Disease control Sponsor: Indonesia University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This study tests whether a high-energy liquid formula with added vitamins can improve nutrition in children under 5 who have chronic cholestasis (a liver condition that blocks bile flow) and severe malnutrition. Fifteen children will drink the formula for 14 days, and researchers will measure blood markers of nutrition (prealbumin and IGF-1) before and after. The goal is to see if this simple dietary approach can help these children grow and stay healthier.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
high-energy liquid formula with micronutrients
What this could lead to
If it works, this could point toward a simple dietary treatment to improve growth and nutrition in young children with liver disease.
What could go wrong
This is a very small, early study with only 15 children and no control group. Results may not apply to all children, and the diet may be hard to tolerate.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 15 people

The number the study aims to enrol. It can still change while the study runs.

Started

Apr 2026

Expected to finish

Jul 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

Up to 5 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Children under 5 years old * Diagnosed with chronic cholestasis and severe malnutrition * Parental/guardian informed consent * Willingness to use a nasogastric tube (NGT) if indicated * Covered by national health insurance or other insurance Exclusion Criteria: * Comorbidities (heart failure, chronic kidney disease, HIV) * Severe acute infections (acute gastroenteritis, dengue fever, pneumonia) * Post-liver transplant * Post-Kasai portoenterostomy (jaundice-free) * Currently exclusively breastfeeding * Use of steroids or NSAIDs within two weeks prior to the study. * Receiving a transfusion of whole blood, fresh frozen plasma, or platelets within one week prior to the study

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Chronic cholestasis are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

cholestasis Malnutrition nutritional deficiency disease protein-energy malnutrition

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Chronic cholestasis Pediatric cholestasis Severe malnutrition

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Faculty of Medicine, University of Indonesia, Jakarta, DKI Jakarta 10430

    RECRUITING

    Jakarta Pusat, DKI Jakarta, 10430, Indonesia